George Sulamanidze
Research Subjects
George Sulamanidze has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy V. Nikishin
Russian Office of the APTOS LLC, Territory of Skolkovo Innovation Center, Bolshoy Boulevard, 42, Building 1, Rooms 873 and 885, 121205 Moscow, Russia
5 shared publications Souphiyeh Samizadeh
King’s College London
5 shared publications- Konstantin Sulamanidze
Total Charm Clinic, APTOS
4 shared publications - Marlen Sulamanidze
Total Charm Clinic, APTOS
4 shared publications - Pavel Burko
Department of Biomedical Sciences Synergy University Moscow Russia
4 shared publications Kajaia Albina
Department of Clinic of Plastic Surgery and Dermatology “Total Charm
3 shared publications
Latest Publications
- 22 May 2026
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 2,p. 74-84
A new injectable filler based on hyaluronic and poly-L-lactic acids: clinical evaluation for aesthetic and post-traumatic indications
Objective. To evaluate clinical effectiveness and safety of Ellagen injectable dermal filler containing a combination of hyaluronic and poly-L-lactic acids for correction of age-related skin changes in the face, neck and décollete, as well as face and body skin scars. Material and methods. The filler was injected twice with a 60-day interval. Effectiveness for age-related changes was assessed in 60, 120, and 180 days after the first injection using Wrinkle Severity Rating Scale (WSRS) and Lemperle scale. POSAS (Patient and Observer Scar Assessment Scale) was used to assess scars. Overall aesthetic improvement was evaluated with Global Aesthetic Improvement Scale (GAIS). Results. Fifty patients (age 25–58 years, 88% female) were enrolled; 46 ones were analyzed. Among 37 patients with age-related indications, significant improvement was observed after 180 days: mean WSRS score reduction by 1.22 points (100% improved by ≥1 point) and mean Lemperle score reduction by 0.86 points (70% improved by ≥1 point). Improvement was similar across different areas (cheeks, perioral area, preauricular area, neck). Among 20 patients with scarring, POSAS scores improved significantly by 7.00 (physician assessment) and 5.05 points (patient assessment) after 180 days. After 60 days, all patients showed GAIS improvement. After 180 days, 89% of aesthetic and 85% of scar cases improved. All adverse effects were expected and regressed without intervention. Conclusion. Ellagen demonstrated a clear rejuvenation effect, including wrinkle reduction, improved aesthetic skin characteristics, and decreased scar severity. Safety profile was assessed as favorable.
- 22 May 2026
- Published by Media Sphere Publishing Group in Plastic Surgery and Aesthetic Medicine
- No. 2,p. 74-84
A new injectable filler based on hyaluronic and poly-L-lactic acids: clinical evaluation for aesthetic and post-traumatic indications
Objective. To evaluate clinical effectiveness and safety of Ellagen injectable dermal filler containing a combination of hyaluronic and poly-L-lactic acids for correction of age-related skin changes in the face, neck and décollete, as well as face and body skin scars. Material and methods. The filler was injected twice with a 60-day interval. Effectiveness for age-related changes was assessed in 60, 120, and 180 days after the first injection using Wrinkle Severity Rating Scale (WSRS) and Lemperle scale. POSAS (Patient and Observer Scar Assessment Scale) was used to assess scars. Overall aesthetic improvement was evaluated with Global Aesthetic Improvement Scale (GAIS). Results. Fifty patients (age 25–58 years, 88% female) were enrolled; 46 ones were analyzed. Among 37 patients with age-related indications, significant improvement was observed after 180 days: mean WSRS score reduction by 1.22 points (100% improved by ≥1 point) and mean Lemperle score reduction by 0.86 points (70% improved by ≥1 point). Improvement was similar across different areas (cheeks, perioral area, preauricular area, neck). Among 20 patients with scarring, POSAS scores improved significantly by 7.00 (physician assessment) and 5.05 points (patient assessment) after 180 days. After 60 days, all patients showed GAIS improvement. After 180 days, 89% of aesthetic and 85% of scar cases improved. All adverse effects were expected and regressed without intervention. Conclusion. Ellagen demonstrated a clear rejuvenation effect, including wrinkle reduction, improved aesthetic skin characteristics, and decreased scar severity. Safety profile was assessed as favorable.
- 16 November 2025
- Published by Springer Nature
- p. 565-580
APTOS Excellence: Methods for Facial Rejuvenation
- 16 November 2025
- Published by Springer Nature
- p. 565-580
APTOS Excellence: Methods for Facial Rejuvenation
- Open Access
- 16 October 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (10) , e70502
Benefits of P( LA / CL )‐Hyaluronic Acid Threads With Innovative Hyaluronic Acid Coating Technology ( NAMICA )—Preclinical Test Results
Objective: To evaluate the biocompatibility and biostimulatory effects of P(LA/CL)‐Hyaluronic Acid Threads with Innovative Hyaluronic Acid Coating Technology (NAMICA) threads in a porcine model, focusing on collagen synthesis, hydration, and inflammatory response. Methods: This study utilized a controlled laboratory setting to compare the safety and biostimulation capacity of the new P(LA/CL)‐HA threads produced with NAMICA technology against the previous generation thread. Threads were implanted into hybrid female pigs (Mangalitsa × Duroc), followed by histological analysis at 7, 21, 30, 90, and 180 days post‐implantation to assess collagen types I and III, elastin fibers, and tissue reaction. Results: P(LA/CL)+HA threads significantly enhanced collagen type I (mean 71.12%, up to 85.90%) and type III (mean 12.18%, up to 20.70%) with minimal inflammation. Elastin fiber content increased over time, with a peak of 2.82% at 180 days in subcutaneous tissue. Capsule thickness around P(LA/CL) threads decreased over time (from 64.28 to 27.23 μm), indicating improved integration. Conclusion: The P(LA/CL)‐HA threads with NAMICA technology exhibit significant advantages in non‐surgical skin rejuvenation by combining mechanical support with biochemical benefits. They not only lift and volumize but also release hyaluronic acid gradually, enhancing tissue hydration and collagen production while minimizing inflammation. Further studies will validate these benefits in human subjects, potentially establishing new standards for aesthetic treatments.
- 16 October 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (10) , e70502
Open AccessBenefits of P( LA / CL )‐Hyaluronic Acid Threads With Innovative Hyaluronic Acid Coating Technology ( NAMICA )—Preclinical Test Results
Objective: To evaluate the biocompatibility and biostimulatory effects of P(LA/CL)‐Hyaluronic Acid Threads with Innovative Hyaluronic Acid Coating Technology (NAMICA) threads in a porcine model, focusing on collagen synthesis, hydration, and inflammatory response. Methods: This study utilized a controlled laboratory setting to compare the safety and biostimulation capacity of the new P(LA/CL)‐HA threads produced with NAMICA technology against the previous generation thread. Threads were implanted into hybrid female pigs (Mangalitsa × Duroc), followed by histological analysis at 7, 21, 30, 90, and 180 days post‐implantation to assess collagen types I and III, elastin fibers, and tissue reaction. Results: P(LA/CL)+HA threads significantly enhanced collagen type I (mean 71.12%, up to 85.90%) and type III (mean 12.18%, up to 20.70%) with minimal inflammation. Elastin fiber content increased over time, with a peak of 2.82% at 180 days in subcutaneous tissue. Capsule thickness around P(LA/CL) threads decreased over time (from 64.28 to 27.23 μm), indicating improved integration. Conclusion: The P(LA/CL)‐HA threads with NAMICA technology exhibit significant advantages in non‐surgical skin rejuvenation by combining mechanical support with biochemical benefits. They not only lift and volumize but also release hyaluronic acid gradually, enhancing tissue hydration and collagen production while minimizing inflammation. Further studies will validate these benefits in human subjects, potentially establishing new standards for aesthetic treatments.
- Open Access
- 26 September 2025
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 106 (5) , 763-775
Long-term efficacy of poly(L-lactide-co-ε-caprolactone) threads with hyaluronic acid nanoparticles: an in vivo skin remodeling study
BACKGROUND: Modern thread-lifting techniques aim to achieve an immediate mechanical lifting effect and provide a prolonged biostimulatory action directed at remodeling dermal structures. AIM: This study aimed to perform a histomorphological evaluation of the effects of monofilament P(LA/CL)-HA-nano threads on skin remodeling in a biomedical experiment and compare their outcomes with those of P(LA/CL)-HA threads and intact skin. METHODS: The study included five clinically healthy female Large White pigs aged 4 months weighing 40 ± 1.2 kg on average. Each animal underwent implantation of two types of threads: P(LA/CL)-HA and P(LA/CL)-HA-nano. Euthanasia of the animals and histomorphological analysis were performed on days 7, 21, 30, 90, and 180. Intact skin was considered the control. The following parameters were assessed: dermal thickness, content of type I and type III collagen fibers, and elastin levels. Histological staining included hematoxylin and eosin, Weigert–Van Gieson, and Picrosirius Red with polarized light analysis. Statistical analysis was conducted using the Wilcoxon signed-rank test. Differences were considered significant at p 0.05. RESULTS: P(LA/CL)-HA-nano thread implantation resulted in significantly increased dermal thickness (day 180, p = 0.0431), increased type I collagen density in the dermis (day 90, p = 0.0431) and hypodermis (all time points, p 0.05), and enhanced type III collagen synthesis in the hypodermis from day 21 (p = 0.0431). A significant increase in elastin levels in the dermis was observed on days 90 and 180 (p = 0.0431). Distinct kinetics of tissue remodeling were noted compared with non-modified P(LA/CL)-HA threads. CONCLUSION: P(LA/CL)-HA-nano threads exhibit pronounced bioactive properties, promoting structural remodeling of skin tissues.
- 26 September 2025
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 106 (5) , 763-775
Open AccessLong-term efficacy of poly(L-lactide-co-ε-caprolactone) threads with hyaluronic acid nanoparticles: an in vivo skin remodeling study
BACKGROUND: Modern thread-lifting techniques aim to achieve an immediate mechanical lifting effect and provide a prolonged biostimulatory action directed at remodeling dermal structures. AIM: This study aimed to perform a histomorphological evaluation of the effects of monofilament P(LA/CL)-HA-nano threads on skin remodeling in a biomedical experiment and compare their outcomes with those of P(LA/CL)-HA threads and intact skin. METHODS: The study included five clinically healthy female Large White pigs aged 4 months weighing 40 ± 1.2 kg on average. Each animal underwent implantation of two types of threads: P(LA/CL)-HA and P(LA/CL)-HA-nano. Euthanasia of the animals and histomorphological analysis were performed on days 7, 21, 30, 90, and 180. Intact skin was considered the control. The following parameters were assessed: dermal thickness, content of type I and type III collagen fibers, and elastin levels. Histological staining included hematoxylin and eosin, Weigert–Van Gieson, and Picrosirius Red with polarized light analysis. Statistical analysis was conducted using the Wilcoxon signed-rank test. Differences were considered significant at p 0.05. RESULTS: P(LA/CL)-HA-nano thread implantation resulted in significantly increased dermal thickness (day 180, p = 0.0431), increased type I collagen density in the dermis (day 90, p = 0.0431) and hypodermis (all time points, p 0.05), and enhanced type III collagen synthesis in the hypodermis from day 21 (p = 0.0431). A significant increase in elastin levels in the dermis was observed on days 90 and 180 (p = 0.0431). Distinct kinetics of tissue remodeling were noted compared with non-modified P(LA/CL)-HA threads. CONCLUSION: P(LA/CL)-HA-nano threads exhibit pronounced bioactive properties, promoting structural remodeling of skin tissues.
- Open Access
NAMICA Encapsulation Technology in an Animal Model: MICROscale vs. NANOscale Hyaluronic Acid Particles in Skin Remodeling (Part 2)
Hyaluronic acid (HA), an integral non-sulfated glycosaminoglycan, plays a pivotal role in numerous biological functions within the extracellular matrix, crucially influencing tissue hydration and cellular activities. These findings position it as a key substance in both aesthetic interventions and regenerative medicine. This study evaluated the skin remodeling efficacy of poly(L-lactide-co-ε-caprolactone) (P(LA/CL)) threads embedded with HA particles at both the microscale (P(LA/CL)-HA-micro) and nanoscale (P(LA/CL)-HA-nano) utilizing NAMICA encapsulation technology. This investigation was conducted over a six-month period in an animal model. These threads were engineered to administer HA gradually, thereby potentially augmenting the therapeutic impacts on the skin, enhancing the bioavailability of HA, and prolonging the benefits. Methodologically, the research conformed to the ARRIVE guidelines, incorporating specific inclusion and exclusion criteria for the animal model. The threads were surgically implanted, and a series of histological indicators were evaluated at scheduled intervals to determine their influence on the structural properties of the skin. The findings indicated that both P(LA/CL)-HA-micro and P(LA/CL)-HA-nano threads demonstrated potential in skin remodeling. Notably, the P(LA/CL)-HA-nano threads may have provided some advantages in enhancing certain structural aspects of the skin. The integration of micro- and nano-HA formulations through NAMICA technology might address individual limitations and synergistically promote biorevitalization in skin remodeling. Nevertheless, the intricate interactions between the biomaterials and hosted tissue underscored in this analysis suggest that additional investigations, especially using human models, are essential to fully discern the clinical implications and refine therapeutic approaches for skin remodeling via these new technologies.
Open AccessNAMICA Encapsulation Technology in an Animal Model: MICROscale vs. NANOscale Hyaluronic Acid Particles in Skin Remodeling (Part 2)
Hyaluronic acid (HA), an integral non-sulfated glycosaminoglycan, plays a pivotal role in numerous biological functions within the extracellular matrix, crucially influencing tissue hydration and cellular activities. These findings position it as a key substance in both aesthetic interventions and regenerative medicine. This study evaluated the skin remodeling efficacy of poly(L-lactide-co-ε-caprolactone) (P(LA/CL)) threads embedded with HA particles at both the microscale (P(LA/CL)-HA-micro) and nanoscale (P(LA/CL)-HA-nano) utilizing NAMICA encapsulation technology. This investigation was conducted over a six-month period in an animal model. These threads were engineered to administer HA gradually, thereby potentially augmenting the therapeutic impacts on the skin, enhancing the bioavailability of HA, and prolonging the benefits. Methodologically, the research conformed to the ARRIVE guidelines, incorporating specific inclusion and exclusion criteria for the animal model. The threads were surgically implanted, and a series of histological indicators were evaluated at scheduled intervals to determine their influence on the structural properties of the skin. The findings indicated that both P(LA/CL)-HA-micro and P(LA/CL)-HA-nano threads demonstrated potential in skin remodeling. Notably, the P(LA/CL)-HA-nano threads may have provided some advantages in enhancing certain structural aspects of the skin. The integration of micro- and nano-HA formulations through NAMICA technology might address individual limitations and synergistically promote biorevitalization in skin remodeling. Nevertheless, the intricate interactions between the biomaterials and hosted tissue underscored in this analysis suggest that additional investigations, especially using human models, are essential to fully discern the clinical implications and refine therapeutic approaches for skin remodeling via these new technologies.
- Open Access
- 12 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70077
Efficacy of Lifting Threads Composed of Poly(L‐Lactide‐Co‐ε‐Caprolactone) Copolymers Coated With Hyaluronic Acid: A Long‐Term Study on Biorevitalizing Properties in Skin Remodeling
Background: Facial thread lifting, which is popular in aesthetic medicine because of its minimal invasiveness, has led to advancements in the use of biodegradable polymers such as poly(L‐lactide‐co‐ε‐caprolactone) (P(LA/CL)) and its hyaluronic acid‐coated variant (P(LA/CL)‐HA). These developments enhance biocompatibility and efficacy, offering prolonged benefits through better biostimulation and tissue integration.Methods: A controlled experiment involving five 4‐month‐old female pigs compared the effectiveness of P(LA/CL) and P(LA/CL)‐HA threads over six months. After being implanted into the subcutaneous layer parallel to the skin of each pig, the threads were evaluated through histological analysis at intervals (7, 21, 30, 90, and 180 days) to assess changes in dermal and hypodermal structures, collagen types, elastin levels, and tissue integration via stains such as hematoxylin and eosin (H&E), Weigert‐Van Gieson, and Sirius Red.Results: P(LA/CL) and P(LA/CL)‐HA threads significantly led to dermal and hypodermal remodeling. By day 180, a comparative analysis via the Wilcoxon test revealed that P(LA/CL)‐HA significantly outperformed P(LA/CL) in most histological indicators because of the biostimulatory effects of hyaluronic acid.Conclusions: Our study investigated the effects of two types of bioabsorbable threads, P(LA/CL) and P(LA/CL)‐HA, on skin remodeling over 180 days in a porcine model. These results highlight the significant role of thread composition in tissue remodeling and suggest that incorporating HA could optimize therapeutic and aesthetic outcomes. Further clinical research is necessary to confirm these findings in human subjects.
- 12 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70077
Open AccessEfficacy of Lifting Threads Composed of Poly(L‐Lactide‐Co‐ε‐Caprolactone) Copolymers Coated With Hyaluronic Acid: A Long‐Term Study on Biorevitalizing Properties in Skin Remodeling
Background: Facial thread lifting, which is popular in aesthetic medicine because of its minimal invasiveness, has led to advancements in the use of biodegradable polymers such as poly(L‐lactide‐co‐ε‐caprolactone) (P(LA/CL)) and its hyaluronic acid‐coated variant (P(LA/CL)‐HA). These developments enhance biocompatibility and efficacy, offering prolonged benefits through better biostimulation and tissue integration.Methods: A controlled experiment involving five 4‐month‐old female pigs compared the effectiveness of P(LA/CL) and P(LA/CL)‐HA threads over six months. After being implanted into the subcutaneous layer parallel to the skin of each pig, the threads were evaluated through histological analysis at intervals (7, 21, 30, 90, and 180 days) to assess changes in dermal and hypodermal structures, collagen types, elastin levels, and tissue integration via stains such as hematoxylin and eosin (H&E), Weigert‐Van Gieson, and Sirius Red.Results: P(LA/CL) and P(LA/CL)‐HA threads significantly led to dermal and hypodermal remodeling. By day 180, a comparative analysis via the Wilcoxon test revealed that P(LA/CL)‐HA significantly outperformed P(LA/CL) in most histological indicators because of the biostimulatory effects of hyaluronic acid.Conclusions: Our study investigated the effects of two types of bioabsorbable threads, P(LA/CL) and P(LA/CL)‐HA, on skin remodeling over 180 days in a porcine model. These results highlight the significant role of thread composition in tissue remodeling and suggest that incorporating HA could optimize therapeutic and aesthetic outcomes. Further clinical research is necessary to confirm these findings in human subjects.
- Open Access
Long-Term Efficacy of Poly(L-lactide-co-ε-caprolactone) Copolymer Lifting Threads with Encapsulated MICROscale Hyaluronic Acid Particles Using NAMICA Technology: Investigating Biorevitalizing Effects in Skin Remodeling (Part 1)
Facial thread lifting with absorbable threads such as poly(L-lactide-co-ε-caprolactone) (P(LA/CL)) has been explored in an animal model. This experimental study utilized P(LA/CL)-HA-micro threads enhanced with hyaluronic acid microencapsulation via NAMICA technology in five four-month-old female pigs. The effects were compared to those of P(LA/CL)-HA threads over a six-month period through histological analysis. The results indicated improvements in skin remodeling, with P(LA/CL)-HA-micro threads enabling controlled and prolonged release of hyaluronic acid, leading to sustained improvements in tissue structure. These findings suggest that microencapsulated threads could enhance therapeutic outcomes; however, these results are preliminary and derived from an animal model. Further research and clinical trials are necessary to confirm these benefits in human subjects.
Open AccessLong-Term Efficacy of Poly(L-lactide-co-ε-caprolactone) Copolymer Lifting Threads with Encapsulated MICROscale Hyaluronic Acid Particles Using NAMICA Technology: Investigating Biorevitalizing Effects in Skin Remodeling (Part 1)
Facial thread lifting with absorbable threads such as poly(L-lactide-co-ε-caprolactone) (P(LA/CL)) has been explored in an animal model. This experimental study utilized P(LA/CL)-HA-micro threads enhanced with hyaluronic acid microencapsulation via NAMICA technology in five four-month-old female pigs. The effects were compared to those of P(LA/CL)-HA threads over a six-month period through histological analysis. The results indicated improvements in skin remodeling, with P(LA/CL)-HA-micro threads enabling controlled and prolonged release of hyaluronic acid, leading to sustained improvements in tissue structure. These findings suggest that microencapsulated threads could enhance therapeutic outcomes; however, these results are preliminary and derived from an animal model. Further research and clinical trials are necessary to confirm these benefits in human subjects.
- Open Access
- 28 December 2024
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 4, 147
Consensus on APTOS threads – excellence product line models selection rule for midface application
- 28 December 2024
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 4, 147
Open AccessConsensus on APTOS threads – excellence product line models selection rule for midface application
- 17 May 2024
- Published by Springer Nature
- p. 263-267
Thread Lifting: Criteria for Optimal Candidate Selection
- 17 May 2024
- Published by Springer Nature
- p. 263-267
Thread Lifting: Criteria for Optimal Candidate Selection
- 17 May 2024
- Published by Springer Nature
- p. 269-279
Thread Lifting: Treatment Procedure